Asian Development Bank (ADB) has approved a $60 million commitment to OrbiMed Asia’s latest vehicle, OrbiMed Asia Partners III, which is targeting $450 million.
The investor had previously invested $60 million in the $300 million OrbiMed Asia Partners II in 2014. Both funds invest in healthcare companies across the Asia Pacific region.
Platinum subscribers may click here for the ADB’s full profile, including key contacts, allocation strategy and fund investments.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: